Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2001 Q1- Text added to 2001 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
6th grade Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
6th grade Good
|
New words:
Additionally, advertising, aimed, Aliprandi, androgen, deferred, deferring, delivery, dermatology, discount, driven, dysfunction, Excluding, expand, female, fiscal, frailty, France, fully, Germany, Gian, GlaxoSmithKline, goodwill, growth, higher, hormone, hypogonadism, impairment, impossible, indefinite, Indenture, intangible, Kingdom, larger, letter, male, multiple, NDA, oncology, partially, payable, people, placement, post, principle, put, reassessment, reclassified, Reg, replacement, retroactive, sexual, Specimen, standard, substance, TAP, transferred, translation, Treasury, Trust, warrant
Removed:
active, molecule, progesterone, small, specifically
Valuein 2001 Q1 filing- Value in 2001 Q2 filing
Original filings
Filing view